# metaMe Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/metame-health

- Industry: Medical Devices & Equipment
- Headquarters: Chicago, US
- Website: www.metamehealth.com
- Total disclosed funding: $3.8M
- Latest round: Seed (Aug 6, 2019)
- Investors on record: 2

## About

Based in Chicago, US, and founded in 2016 by its CEO, Timothy Rudolphi, and CPO, Danny Bernstein, metaMe Health, Inc. operates as a medical device company. In August 2019, metaMe Health, Inc. raised USD 3.8 million in seed funding led by a new investor, LionBird, with participation from new investor Hemi Ventures and an unspecified investor. 

metaMe Health, Inc.'s product line includes Regulora for the treatment of abdominal pain due to irritable bowel syndrome. Its behavior-based intervention is administered over a three-month period through seven automated sessions hosted on the company’s metaMe Connect mobile platform, which collects patients’ adherence data and reported outcomes. The company's pipeline also includes digital health products for gastroesophageal reflux disease (GERD) and inflammatory bowel disease (IBD) with IBS overlap.

metaMe Health, Inc. will use the funding to support the continued development of Regulora, particularly through the initiation of a large, randomized controlled trial of IBS patients.

## Funding rounds

- Seed, Aug 6, 2019, $3.8M — LionBird, Hemi Ventures

## Investors

- LionBird (https://capitalatlas.ai/funds/lionbird) — Seed
- Hemi Ventures (https://capitalatlas.ai/funds/hemi-ventures) — Seed